Literature DB >> 12924636

Experimental model of acute pancreatitis in Wistar rat: glucocorticoid treatment profile.

Laura Iris Cosen-Binker1, Marcelo Gustavo Binker, Gustavo Negri, Osvaldo Tiscornia.   

Abstract

Severe acute pancreatitis may be triggered by an extrapancreatic insult at the peri-Vaterian duodenum such as that occurring in the short-term, 20 min closed duodenal loop model in Wistar rat, which mimics biliary acute pancreatitis or that following endoscopy. Glucocorticoids are immunological modulators whose therapeutic value is worth investigating. Wistar male rats were used under standardized conditions. Acute pancreatitis was induced by instillation of a 7% sodium tauraocholate solution with 5 drops of methylene blue to monitor absence of duodenal bilio pancreatic reflux into the peri-Vaterian duodenum for 20 min. Detection of biliopancreatic reflux with methylene blue was an exclusion criterion. Different doses and times of administration of subcutaneous hydrocortisone were evaluated. Biochemical assays were carried out in blood samples and pancreatic and lung tissue, while histpathological studies were done in the pancreas, lung liver, duodenum, spleen, kidneys, suprarenal glands, and stomach. Animals subjected to the experimental model developed severe acute pancreatitis. According to the dose and time of administration, hydrocortisone therapy was effective and beneficial at a dose of 4 mg/kg give 30 min before inducing acute pancreatitis. It was ineffective when doses were <4 mg/kg and given before sodium taurocholate harmful when the dose was >4 mg/kg and given either before or after. Thus, the proposed model is valid and useful to study the initiation mechanism of acute pancreatitis caused extrapancreatically while its amelioration by glucocorticoid is related the dose and time factor to achieve therapeutical results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12924636     DOI: 10.1023/a:1024791101859

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease.

Authors:  C Schäfer; J A Williams
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

Review 2.  Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine.

Authors:  B A Jones; G J Gores
Journal:  Am J Physiol       Date:  1997-12

Review 3.  Neural-immune interactions in health and disease.

Authors:  E M Sternberg
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Fatal pancreatitis, a consequence of excessive leukocyte stimulation?

Authors:  H Rinderknecht
Journal:  Int J Pancreatol       Date:  1988-03

5.  Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality.

Authors:  B J Ammori; P C Leeder; R F King; G R Barclay; I G Martin; M Larvin; M J McMahon
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

6.  Increased monocyte cytokine production in association with systemic complications in acute pancreatitis.

Authors:  C J McKay; G Gallagher; B Brooks; C W Imrie; J N Baxter
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

7.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.

Authors:  R I Scheinman; A Gualberto; C M Jewell; J A Cidlowski; A S Baldwin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.

Authors:  E Caldenhoven; J Liden; S Wissink; A Van de Stolpe; J Raaijmakers; L Koenderman; S Okret; J A Gustafsson; P T Van der Saag
Journal:  Mol Endocrinol       Date:  1995-04

9.  Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

Authors:  J Norman; M Franz; J Messina; A Riker; P J Fabri; A S Rosemurgy; W R Gower
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

Review 10.  Pancreatitis secondary to percutaneous liver biopsy-associated hemobilia.

Authors:  E C Van Os; B T Petersen
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  6 in total

Review 1.  Recent insights into the cellular mechanisms of acute pancreatitis.

Authors:  Laura I Cosen-Binker; Herbert Y Gaisano
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

2.  Influence of hydrocortisone, prednisolone, and NO association on the evolution of acute pancreatitis.

Authors:  Laura Iris Cosen-Binker; Marcelo Gustavo Binker; Rodica Cosen; Gustavo Negri; Osvaldo Tiscornia
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

3.  Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins.

Authors:  Emad Kandil; Yin-Yao Lin; Martin-H Bluth; Hong Zhang; Gabriel Levi; Michael-E Zenilman
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Qian Ye; Xin-Ge Jiang; Mei-Li Ma; Fei-Bo Zhu; Rui-Ping Zhang; Qi-Hui Cheng
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

Review 5.  Corticosteroid treatment for acute/acute-on-chronic experimental and naturally occurring pancreatitis in several species: a scoping review to inform possible use in dogs.

Authors:  Kari-Anne Bjørnkjær-Nielsen; Charlotte Reinhard Bjørnvad
Journal:  Acta Vet Scand       Date:  2021-07-13       Impact factor: 1.695

6.  Influence of acute pancreatitis on the in vitro responsiveness of rat mesenteric and pulmonary arteries.

Authors:  Enilton A Camargo; Maria Andréia Delbin; Tatiane Ferreira; Elen Ct Landucci; Edson Antunes; Angelina Zanesco
Journal:  BMC Gastroenterol       Date:  2008-05-29       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.